USANA Health Sciences Major Shareholder Sells $547,330 in Stock (USNA)
USANA Health Sciences (NASDAQ:USNA) major shareholder Holdings Ltd Gull sold 7,000 shares of USANA Health Sciences stock on the open market in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $78.19, for a total transaction of $547,330.00. Following the sale, the insider now directly owns 6,588,167 shares of the company’s stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
USNA has been the subject of a number of recent research reports. Analysts at Janney Montgomery Scott raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $49.00 to $72.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $54.00 to $75.00 in a research note to investors on Wednesday, July 24th. Finally, analysts at DA Davidson reiterated a “neutral” rating on shares of USANA Health Sciences (NASDAQ:USNA) in a research note to investors on Wednesday, July 24th. They now have a $92.00 price target on the stock, up previously from $80.00.
Four equities research analysts have rated the stock with a hold rating, USANA Health Sciences has a consensus rating of “Hold” and a consensus target price of $74.28.
USANA Health Sciences (NASDAQ:USNA) traded up 1.60% on Friday, hitting $82.07. The stock had a trading volume of 138,666 shares. USANA Health Sciences has a 52 week low of $30.51 and a 52 week high of $87.40. The stock’s 50-day moving average is $79.50 and its 200-day moving average is $64.98. The company has a market cap of $1.132 billion and a price-to-earnings ratio of 14.89.
USANA Health Sciences (NASDAQ:USNA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $1.72 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.33 by $0.39. The company had revenue of $189.10 million for the quarter, compared to the consensus estimate of $176.60 million. During the same quarter in the prior year, the company posted $1.11 earnings per share. The company’s quarterly revenue was up 17.5% on a year-over-year basis. On average, analysts predict that USANA Health Sciences will post $5.42 earnings per share for the current fiscal year.
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.